Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGD | P52209 | 3/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | TPI1 | P60174 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | PGK1 | P00558 | 1/20 | 0.37 |
| ▸ | PGK2 | P07205 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MPI | P34949 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16322088 | 1.00 | PGD (0.43) | PGDPDE4ATPI1LMNAPGK1 | |
| SCHEMBL4136973 | 1.00 | PGD (0.43) | PGDPDE4ATPI1LMNAPGK1 | |
| SCHEMBL9738422 | 1.00 | PGD (0.43) | PGDPDE4ATPI1LMNAPGK1 | |
| SCHEMBL19512307 | 1.00 | PGD (0.43) | PGDPDE4ATPI1LMNAPGK1 | |
| SCHEMBL9737043 | 1.00 | PGD (0.43) | PGDPDE4ATPI1LMNAPGK1 | |
| SCHEMBL8472515 | 1.00 | PGD (0.43) | PGDPDE4ATPI1LMNAPGK1 | |
| SCHEMBL851610 | 1.00 | PGD (0.43) | PGDPDE4ATPI1LMNAPGK1 | |
| SCHEMBL24438 | 1.00 | PGD (0.43) | PGDPDE4ATPI1LMNAPGK1 | |
| Phosphoric Acid SCHEMBL18011882 | 0.98 | PGD (0.42) | PGDPDE4ATPI1LMNAPGK1 | |
| SCHEMBL8142384 | 0.98 | PGD (0.42) | PGDPDE4ATPI1LMNAPGK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713470-A1 | METHOD FOR PRODUCING D-TALITOL, D-TAGATOSE, AND D-PSICOSE | Annikki GmbH (AT) | 2026-03-25 | — | — | EP | disclosed |
| EP-4680760-A2 | METHOD FOR PRODUCING AN AQUEOUS SOLUTION CONTAINING D-PSICOSE | Annikki GmbH (AT) | 2026-01-21 | — | — | EP | disclosed |
| EP-4520839-A2 | PROCESS FOR PREPARING AN AQUEOUS SOLUTION CONTAINING D-PSICOSE | Annikki GmbH (AT) | 2025-03-12 | — | — | EP | disclosed |
| WO-2024236043-A1 | METHOD FOR PRODUCING D-TALITOL, D-TAGATOSE, AND D-PSICOSE | ANNIKKI GMBH (AT) | 2024-11-21 | — | — | WO | disclosed |
| EP-4464785-A1 | PROCESS FOR PRODUCING D-TALITOL, D-TAGATOSE AND D-PSICOSE | Annikki GmbH (AT) | 2024-11-20 | — | — | EP | disclosed |
| EP-4464786-A1 | PROCESS FOR THE PREPARATION OF AQUEOUS SOLUTIONS CONTAINING D-PSICOSE OR L-PSICOSE | Annikki GmbH (AT) | 2024-11-20 | — | — | EP | disclosed |
| EP-4446422-A2 | PROCESS FOR PRODUCING AN AQUEOUS SOLUTION CONTAINING L-PSICOSE | Annikki GmbH (AT) | 2024-10-16 | — | — | EP | disclosed |
| WO-2024189215-A2 | METHOD FOR PRODUCING AN AQUEOUS SOLUTION CONTAINING D-PSICOSE | ANNIKKI GMBH (AT) | 2024-09-19 | — | — | WO | disclosed |
| EP-4431614-A1 | PROCESS FOR THE PREPARATION OF AQUEOUS SOLUTIONS CONTAINING D-PSICOSE OR L-PSICOSE | Annikki GmbH (AT) | 2024-09-18 | — | — | EP | disclosed |
| EP-1864669-B1 | APPLICATION OF D-PSICOSE TO SUPPRESSION OF ABNORMAL CIRCADIAN INCREASE IN BLOOD GLUCOSE LEVEL | RARE SUGAR PRODUCTION TECHNICAL RES LABORATORIES LLC (JP) | 2018-06-27 | — | — | EP | disclosed |
| WO-2016201110-A1 | METHOD FOR PRODUCING CARBOHYDRATES FROM DIHYDROXYACETONE | KEMBIOTIX LLC (US) | 2016-12-15 | — | — | WO | disclosed |
| US-20090062215-A1 | APPLICATION OF D-PSICOSE TO SUPPRESSION OF ABNORMAL CIRCADIAN INCREASE IN BLOOD GLUCOSE LEVEL | RARE SUGAR PRODUCTION TECHNICAL RESEARCH LABORATORIES LLC (JP) | 2009-03-05 | — | — | US | disclosed |
| EP-1864669-A1 | APPLICATION OF D-PSICOSE TO SUPPRESSION OF ABNORMAL CIRCADIAN INCREASE IN BLOOD GLUCOSE LEVEL | National University Corporation Kagawa University (JP) | 2007-12-12 | — | — | EP | disclosed |
| EP-0506772-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING A PHOSPHOSUGAR | PERSTORP AB (SE) | 1992-10-07 | — | — | EP | disclosed |
| WO-1991009604-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING A PHOSPHOSUGAR | PERSTORP AB (SE) | 1991-07-11 | — | — | WO | disclosed |